Breaking News, Collaborations & Alliances

BD and Ypsomed Partner to Advance High-Viscosity Drug Delivery

Will integrate the BD Neopak XtraFlow Glass Prefillable Syringe with Ypsomed’s YpsoMate 2.25 autoinjector platform.

Author Image

By: Charlie Sternberg

Associate Editor

BD, a global medical technology company, has entered a strategic collaboration with Ypsomed, a developer of injection systems, to advance self-injection solutions for high-viscosity biologic drugs.   In a joint project, Ypsomed and BD have pre-assessed and streamlined integration of the BD Neopak XtraFlow Glass Prefillable Syringe with Ypsomed’s YpsoMate 2.25 autoinjector platform, addressing current limitations by enabling the delivery of higher viscosity (>15cP) biologic drugs in an autoi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters